Garcia Beate Hennie, Omma Katharina Kaino, Småbrekke Lars, Johansen Jeanette Schultz, Skjold Frode, Halvorsen Kjell Hermann
Department of Pharmacy, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Tromsoe, 9037, Norway.
Hospital Pharmacy of North Norway Trust, Tromsø, Norway.
Ther Adv Drug Saf. 2024 Nov 15;15:20420986241299683. doi: 10.1177/20420986241299683. eCollection 2024.
Inappropriate medication prescribing in older patients increases the risk of poorer health outcomes and increased costs. The IMMENSE trial, integrated a clinical pharmacist into the health care team, to improve medication therapy among older patients, and to investigate the impact on acute revisits to hospital.
This study investigated the prevalence of potentially inappropriate medications (PIMs) and prescribing omissions (PPOs) at hospital admission and discharge. It also explored the impact of the pharmacist intervention on PIMs and PPOs, and other factors associated with PIMs and PPOs at discharge.
The STOPP/START criteria version 2 were retrospectively applied at admission and discharge. PIM and PPO changes were compared, and Poisson regression was used to assess factors influencing prevalence at discharge.
At hospital admission, PIM prevalence was 58.6% among intervention patients and 64.8% among control patients. PPO prevalence was 55.3% and 55.5%, respectively. A larger proportion of PIMs identified at admission were resolved by discharge in the intervention group (42.9%) compared to the control group (27.4%). No difference was seen for PPOs. Poisson regression identified a significantly higher risk for PIMs at discharge in the control group compared to the intervention group (IRR 1.255; 95% CI 1.063-1.480, = 0.007), but no effect for PPOs. Patients living in a nursing home, a home care facility, or an institution showed a higher risk of PPOs at discharge compared to patients living at home (IRR 1.378; 95% CI 1.156-1.644, < 0.001).
The IMMENSE intervention significantly reduced the risk of PIMs at discharge, with no effect on PPOs. Living in nursing homes, home care facilities, or institutions prior to hospitalization increased the risk of PPOs at discharge. Pharmacists may contribute to improved medication appropriateness in older hospitalized patients.
老年患者不适当的药物处方会增加健康状况恶化和成本增加的风险。IMMENSE试验将临床药剂师纳入医疗团队,以改善老年患者的药物治疗,并调查对急性再入院的影响。
本研究调查了住院和出院时潜在不适当用药(PIMs)和处方遗漏(PPOs)的发生率。它还探讨了药剂师干预对PIMs和PPOs的影响,以及与出院时PIMs和PPOs相关的其他因素。
在入院和出院时回顾性应用STOPP/START标准第2版。比较PIM和PPO的变化,并使用泊松回归评估影响出院时发生率的因素。
入院时,干预组患者的PIM发生率为58.6%,对照组为64.8%。PPO发生率分别为55.3%和55.5%。与对照组(27.4%)相比,干预组入院时发现的PIMs在出院时得到解决的比例更高(42.9%)。PPOs方面未观察到差异。泊松回归显示,与干预组相比,对照组出院时PIMs的风险显著更高(IRR 1.255;95%CI 1.063 - 1.480,P = 0.007),但对PPOs没有影响。与居家患者相比,住在养老院、家庭护理机构或机构中的患者出院时PPOs的风险更高(IRR 1.378;95%CI 1.156 - 1.644,P < 0.001)。
IMMENSE干预显著降低了出院时PIMs的风险,对PPOs没有影响。住院前住在养老院、家庭护理机构或机构中会增加出院时PPOs的风险。药剂师可能有助于提高老年住院患者的用药合理性。